Zheng Leizhen, Wu Chunxiao, Xi Pan, Zhu Meiling, Zhang Li, Chen Siyu, Li Xiaoping, Gu Jianchun, Zheng Ying
Department of Oncology, Xin Hua Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
BMC Cancer. 2014 Apr 29;14:300. doi: 10.1186/1471-2407-14-300.
Gastric cancer remains a major health issue and a leading cause of death worldwide. This study presented a long-term survival data of gastric cancer registered in Shanghai of China from 1972-2003, with aims to describe the trends as well as the age, sex, stage and tumor sites specific characteristics.
The main source of information on cancer cases was the notification card sending to the registry. The residential status of cancer cases was confirmed by home-visits. The methods of follow-up have been a mixture of both active and passive ones.
We observed an increased trend of survival probability during the last decades. Patients diagnosed during 1972-1976 had a 5-years relative survival rate at 12% for males and 11% for females, respectively, which had dramatically increased to 30% for male and 32% for female patients respectively during the period of 2002-2003. Among the patients diagnosed in 2002-2003, the overall survival probability declined with patient's age at the time of diagnosis. The lowest survival rate was observed among the oldest group, with the median survival time of 0.8 years. Patients diagnosed with stage I had a higher relative survival rate. Patients with cardia cancer had the worst prognosis, with the 5-year relative survival rate of 29%.
The survival probability of patients with gastric cancer in Shanghai has improved significantly during the last decades. Age, stage and site of tumor have an impact on prognosis.
胃癌仍然是一个重大的健康问题,也是全球主要的死亡原因之一。本研究呈现了1972年至2003年在中国上海登记的胃癌患者长期生存数据,旨在描述其发展趋势以及年龄、性别、分期和肿瘤部位的特异性特征。
癌症病例的主要信息来源是发送至登记处的通报卡。通过家访确认癌症病例的居住状况。随访方法包括主动随访和被动随访。
我们观察到在过去几十年中生存概率呈上升趋势。1972年至1976年期间确诊的患者,男性5年相对生存率为12%,女性为11%,而在2002年至2003年期间,男性和女性患者的这一比例分别大幅上升至30%和32%。在2002年至2003年确诊的患者中,总体生存概率随诊断时患者年龄的增加而下降。年龄最大组的生存率最低,中位生存时间为0.8年。I期确诊患者的相对生存率较高。贲门癌患者的预后最差,5年相对生存率为29%。
在过去几十年中,上海胃癌患者的生存概率有显著提高。年龄、分期和肿瘤部位对预后有影响。